Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9
Research Letter
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,123 | Dovepress* | 6,957+ | 1,222 | 8,179 | |
PubMed Central* | 166 | 71 | 237 | ||
Totals | 7,123 | 1,293 | 8,416 | ||
*Since 27 September 2017 |
View citations on PubMed Central and Google Scholar